Proteins of the lipocalin family are known to bind small hydrophobic ligands and are involved in various physiological processes ranging from lipid transport to oxidative stress responses. The genome of the malaria parasite Plasmodium falciparum contains a single protein PF3D7_0925900 with a lipocalin signature. Using crystallography and small-angle X-ray scattering, we show that the protein has a tetrameric structure of typical lipocalin monomers, hence we name it P. falciparum lipocalin (PfLCN), the first lipocalin structurally and functionally characterized in a single-celled eukaryote. We show that PfLCN is expressed in the intraerythrocytic stages of the parasite and localizes to the parasitophorous and food vacuoles. Conditional knockdown of PfLCN impairs parasite development, which can be rescued by treatment with the radical scavenger Trolox or by temporal inhibition of hemoglobin digestion. This suggests a key function of PfLCN in counteracting oxidative stress induced cell damage during multiplication of parasites within red blood cells.
INTRODUCTION
Lipocalins are a diverse family of small proteins (typically 160 -180 residues) whose functional hallmark is their binding to small hydrophobic molecules. Although lipocalins show low overall primary sequence conservation, they share a similar β-barrel structure consisting of eight β-strands that enclose a hydrophobic binding pocket and all are part of the larger protein superfamily of calycins (reviewed in (Flower et al, 2000) ). The conservation of particular residues and interactions across the lipocalin protein family supports a common evolutionary origin and lipocalins have been identified and characterized in mammals, insects, plants and bacteria, with key roles in specialized biological functions including the transport of fatty acids, lipids and hormones, control of cell regulation, cryptic coloration, enzymatic synthesis of prostaglandins, and protection from oxidative stress (Flower, 1996; Ganfornina et al, 2008; Sanchez et al, 2006; Walker et al, 2006; Charron et al, 2008; Bishop, 2000) . Yet, lipocalins have not been identified in archaea, and their identity and function in unicellular eukaryotes, including important human parasites, remains poorly understood.
The malaria parasite Plasmodium falciparum, which is responsible for more than 400,000 deaths each year (WHO, 2019) , is an intracellular parasite that proliferates within a vacuole in its host cell. It establishes itself in its vertebrate host by using hepatocytes for an initial multiplication step before exploiting erythrocytes for exponential growth. To fuel the parasite's rapid growth over its 48 hour erythrocytic lifecycle, the parasite not only feeds on its host cell but also transforms it, establishing new transport systems that allow direct access to nutrients from the surrounding blood stream. Underpinning the malaria parasite's rapid growth are highly efficient membrane synthesis and recycling pathways that provide the structural constituents for cell growth and multiplication. For instance, the phospholipid content of the erythrocyte increases almost fivefold during intraerythrocytic development, as the parasite generates the membranes needed for growth and division (Tran et al, 2016) . Fatty acids, the building blocks of lipids, are typically scavenged from the host but the presence a functional FASII system in the apicoplast (specialized chloroplast-derived organelle) also enables the parasite to synthesize fatty acids de novo (reviewed in (Tarun et al, 2009) ). How these essential building blocks of membranes are transported from the host and within the parasite is not known.
The rapid growth of the parasite in its host cell not only depends on sufficient nutritional uptake but also on a tightly controlled redox homeostasis. In erythrocytes, the primary amino acid source for the parasite is host cell hemoglobin (Hb). Hb degradation occurs in the acidic environment of the digestive or food vacuole (FV) and involves the endocytic uptake of host cell cytosol across both the parasitophorous vacuole membrane (PVM) and the parasite plasma membrane (PPM) (reviewed in (Wunderlich et al, 2012) ). A major waste product of Hb digestion is toxic free heme (ferriprotoporphyrin IX), most of which is detoxified by biomineralization into the inert crystalline form hemozoin. Oxidation of Hb-bound iron during Hb digestion leads to the release of superoxide radicals. The superoxide anion dismutates into hydrogen peroxide, which together with the free iron of Hb digestion can lead to the formation of hydroxyl radicals via the Fenton reaction. These radicals are highly reactive and can cause membrane damage by lipid peroxidation (Jortzik & Becker, 2012; Atamna & Ginsburg, 1993) . It is thus not surprising that Plasmodium infected erythrocytes show much higher levels of reactive oxygen species (ROS) relative to uninfected erythrocytes (Atamna & Ginsburg, 1993) . Protection against oxidative damage is therefore of particular importance for parasite survival and parasites remain reliant on various detoxification pathways including glutathione and thioredoxin redox systems, members of which have been shown to be essential for blood stage parasite development (reviewed in (Müller, 2004; Jortzik & Becker, 2012) ).
In bacterial and eukaryotic cells, members of the lipocalin family are key components of lipid transport and can also mediate control of ROS damage to membranes (Flower, 1996; Ganfornina et al, 2008; Sanchez et al, 2006; Walker et al, 2006; Charron et al, 2008; Bishop, 2000) . To date, no lipocalin has been structurally or functionally characterized in the diverse parasitic phylum of Apicomplexa, and a potential role for members of this protein family in survival and virulence of these important human and livestock pathogens has not been investigated. Here, we identify and characterize a new lipocalin in the human malaria parasite Plasmodium falciparum (PlasmoDB: PF3D7_0925900) based on structural analysis and show that it is essential for parasite survival within erythrocytes.
RESULTS

Identification and evolutionary analysis of lipocalin-like proteins in P. falciparum and related protists
Database analysis on PlasmoDB (Aurrecoechea et al, 2009) revealed PF3D7_0925900 as the only gene in the genome of P. falciparum 3D7 containing a calycin and lipocalin superfamily signature (Mitchell et al, 2019; Pandurangan et al, 2019) . The encoded protein of 217 amino acids length, which we term P. falciparum lipocalin (PfLCN), has an unknown function. It contains an N-terminal signal peptide and its mRNA is most highly expressed during trophozoite development (Otto et al, 2010) . Sequence comparisons show that it is highly conserved between different Plasmodium species with 65% to 99.5% pairwise sequence identities ( Figure S1 ). In contrast, low pairwise identities of 23% to 27% were observed for lipocalin-like proteins in Toxoplasma gondii (GenBank CEL71535), Neospora caninum (GenBank XP_003879719) and Hammondia hammondi (GenBank KEP62611), and blastp searches did not yield any significant sequence alignments to species outside the apicomplexan lineage, where overall pairwise sequence identities to known lipocalin proteins dropped below 20%, making it difficult to detect more distant homologous proteins at the sequence level. Therefore, we relied upon annotations based on libraries of protein signatures provided by the SUPERFAMILY and other databases integrated in InterPro to identify additional putative lipocalins (Mitchell et al, 2019; Pandurangan et al, 2019) . Interestingly, when we did a comparative analysis of the genomes of other apicomplexan parasites and their closest free-living non-parasitic relatives for the presence of proteins belonging to the lipocalin (SSF50814 SUPERFAMILY identifier) and calycin (IPR012674, InterPro identifier) homologous superfamily, we found that most parasitic species encode one to three putative lipocalin-like genes only, while in most of the free living relatives a substantially higher number of putative lipocalin-like genes can be found even when different genome sizes are taken into account ( Figure S2 ). This may hint to a potential gene reduction of the lipocalin family during apicomplexan evolution as an adaptation to the intracellular parasitic lifestyle.
X-ray crystallography of recombinant PfLCN reveals a typical lipocalin structure
Lipocalins have a characteristic structure consisting of eight anti-parallel β-barrel strands that form a hydrophobic binding pocket (Flower, 1996) . To validate PfLCN as a lipocalin, we recombinantly expressed it in E. coli without the signal peptide (all residue numbering and molecular weights that follow reflect this) and determined its structure using X-ray crystallography to a resolution of 2.85 Å ( Figures 1A and B , Figure S3 ). The structure has been deposited with the PDB ID 6TLB. In this crystal structure, PfLCN is arranged as a tetramer and the monomers superimpose with a root mean square deviation (RMSD) <0.5 Å over all Cα atoms, indicating high similarity ( Figure 1A , Movie S1). The tetramer displays a two-fold symmetry and is composed of a dimer of dimers. The dimeric interface is very stable, with a solvation energy of around -17 kcal mol -1 calculated using the PISA server (Krissinel & Henrick, 2007) , and this is strongly driven by hydrophobic effects.
The overall monomeric structure of PfLCN reveals the classic lipocalin fold with a β-barrel calyx core consisting of eight hydrogen-bonded anti-parallel β-strands and an N-terminal α-helix (α3) perpendicular to the lumen of the barrel ( Figure 1B , Movie S2). There is a typical lipocalin binding pocket with a highly hydrophobic environment inside the β-barrel where non-polar ligands usually bind in most lipocalins, for example the many lipophilic ligands of the human lipocalin NGAL (Bao et al, 2015) . The binding pocket of PfLCN can be measured as approximately 20 Å by 20 Å at the widest span, which is in a similar range to other lipocalins (Campanacci et al, 2004; Eichinger et al, 2007) . The bottom of the barrel is closed by the inter-strand hydrogen bonds between β-strands 3 and 6, and also a 3 10 helix. This is a feature also shared with other lipocalins. The available protein structure with the highest degree of similarity to PfLCN is the E. coli lipocalin Blc (Campanacci et al, 2004 ) with a RMSD of 1.7 Å and a modified version of Blc was used as a molecular replacement model during structure determination. Interestingly, structural comparisons of PfLCN with human lipocalins (Breustedt et al, 2006) revealed that amongst these PfLCN has the highest structural similarity with the high-density lipoprotein ApoD (Eichinger et al, 2007) ( Figure S4 ) with a RMSD of 1.8 Å. The sequence homology of both Blc and ApoD when compared to PfLCN are nevertheless low, with 16.8% and 19.2% sequence identity respectively.
The surface charges of PfLCN are distributed mostly on the underside of the barrel and are mainly constituted of positively charged residues. However, both the dimerization face and the binding face are largely composed of non-polar residues, allowing both a hydrophobic effect-driven dimerization and also the direction of hydrophobic ligands into the binding pocket, which contains mostly non-polar residues ( Figure 1C and D) . There are two disulfide bonds located close to each other in each monomer ( Figure 1B) . One disulfide bond (C49-C195) anchors the Cterminal tail to the body of the protein, which is a feature well conserved among lipocalins (Flower, 1996) . However, the other disulfide bond (C47-C72) is more unusual in the family and binds the terminus of α2, the helix that appears to be 'gating' the entrance to the binding pocket, to β4, one of the longest strands of the barrel. The binding pocket in the structure is mostly occluded by the α2 helix, and while this does not rule out the possibility of ligand binding in these conditions, the C47-C72 disulfide bond may be contributing to controlling access to the pocket.
To investigate whether the tetramer observed in the crystal structure was a physiologically relevant oligomer, we performed small-angle X-ray scattering (SAXS) experiments. These confirmed the presence of a tetramer in solution, and that this tetramer exhibits a concentration-dependent equilibrium with dimeric PfLCN (Figure  2 ). The dimer obtained from SAXS modeling spatially superimposes well with the crystallographic dimer, which along with the favorable solvation enthalpy gives an indication that this is a stable, physiological dimer. In the crystallographic tetramer and the SAXS-derived dimer, all binding sites are pointing outwards, allowing each monomer to potentially bind to a ligand in this state and remain functional.
PfLCN localizes to the PV and FV and can integrate into membranes
Having shown that PfLCN is indeed a lipocalin based on its structure, we next determined its localization by endogenously tagging PfLCN with green fluorescent protein (GFP) using the selection-linked integration (SLI) system (Birnbaum et al, 2017) . We additionally introduced a GlmS ribozyme (Prommana et al, 2013) sequence upstream of the 3' untranslated region that allows inducible knockdown of protein expression upon addition of glucosamine to the parasite culture medium ( Figure 3A ). In parallel, we generated a similar parasite line, in which the GlmS ribozyme sequence was inactivated (M9 mutant (Prommana et al, 2013) ). Correct integration of both of the corresponding targeting constructs into the endogenous PfLCN locus was confirmed by PCR ( Figure 3B ). In the following, the resulting parasite lines are referred to as PfLCN-knockdown (LCN-Kd, GlmS-WT sequence) and PfLCN-control parasites (LCN-Con, GlmS-M9 sequence).
Live-cell microscopy of LCN-Kd parasites revealed that in rings and early trophozoites PfLCN-GFP localized to the parasite periphery, suggesting a possible localization on the PVM, the PPM or within the PV itself ( Figure 3C ). In trophozoites and early schizonts, the protein was additionally visible in small, mostly peripheral, focal structures, the FV and in accumulations in the parasite cytoplasm. In schizonts, we mainly observed the PfLCN signal around developing merozoites, in some accumulations in the schizont cytoplasm and in the FV. In contrast, in free merozoites PfLCN was present in the cytosol but no GFP signal was evident around their periphery, excluding a localization to the PPM and further supporting that PfLCN localizes to the PV and possibly on the PVM of the infected erythrocyte ( Figure 3C ).
Given that several lipocalins, including E. coli Blc and human ApoD, have the capability to integrate into membranes (Hernández-Gras & Boronat, 2015; Eichinger et al, 2007; Bishop et al, 1995) , we next investigated the membrane association of PfLCN and performed sequential differential solubilization of lysed parasite membranes. To this aim, saponin (permeabilizes erythrocyte membrane and PVM) pellets of Lip-Kd trophozoite stage parasites were hypotonically lysed to release nonmembrane associated proteins and then sequentially treated with sodium carbonate and Triton X-100 to solubilize peripheral and integral membrane proteins, respectively. Western-Blot analysis using anti-GFP antibodies revealed that an approximately 50 kDa PfLCN-GFP (calculated MW 50.8 kDa) was not only found in the soluble fraction but also in the sodium carbonate and Triton fraction, indicating that it is a soluble protein but that it can also associate with and integrate into membranes ( Figure 3D ). Interestingly, we also detected a higher molecular mass GFP-positive band, which likely represents PfLCN in its dimeric state as previously described for other lipocalins (Bhatia et al, 2012; Van Veen et al, 2006; Kielkopf et al, 2018) and as also supported by our SAXS analysis. In addition to these bands, a third band at around 25 kD was visible that likely represents cleaved GFP. This band is often detected in GFP-fusions in P. falciparum in particular for PV and FV proteins (Klemba et al, 2004; Boddey et al, 2016) and was solely found in the soluble fraction further underlining the specificity of PfLCN's membrane association.
PfLCN is important for parasite survival in erythrocytes
In order to test if PfLCN is essential for blood stage proliferation, we first tried to functionally inactivate it by targeted-gene disruption using the SLI system (Birnbaum et al, 2017) . However, repeated attempts failed to obtain parasites carrying the correctly integrated plasmid, indicating that the gene is likely essential for parasite development.
We next aimed to conditionally downregulate PfLCN expression and to study the influence of this on parasite development. To test whether the GlmS-system can be used to investigate PfLCN function, we first added 2.5 mM glucosamine to tightly synchronized early ring stage LCN-Kd and LCN-Con parasites and measured PfLCN expression 24 hours post glucosamine addition by quantitative western blot analysis. This revealed a >95% knockdown of the protein in LCN-Kd parasites upon glucosamine addition, while no influence on PfLCN expression was seen in LCN-Con parasites, showing efficient regulation of PfLCN expression by the GlmS ribozyme ( Figure 4A ).
To assess the influence of PfLCN knockdown on parasite multiplication, we next quantitated the growth of LCN-Kd and LCN-Con parasites with and without glucosamine using a flow cytometry-based growth assay over four parasite cycles. Addition of glucosamine to LCN-Kd parasites resulted in a pronounced growth defect, which was already visible in the first parasite cycle following glucosamine addition ( Figure 4B ). In contrast, no noticeable growth defect was evident for LCN-Con parasites treated with glucosamine, thereby excluding that the observed growth defect in LCN-Kd parasites is due to glucosamine cytotoxicity. To further verify that the observed reduction in multiplication of LCN-Kd parasites grown in the presence of glucosamine is due to the knockdown of PfLCN, we complemented LCN-Kd parasites with an episomal plasmid, from which the PfLCN coding sequence is expressed as a fusion with mCherry under the constitutive nmd3 promoter (Birnbaum et al, 2017) . As expected, in these parasites the mCherry-tagged PfLCN showed a clear PV localization in addition to a pronounced staining of the parasite FV ( Figure  4C ). Importantly, when we added glucosamine to these complemented parasites, the growth defect was reversed, confirming that knockdown of PfLCN is specific and deleterious for parasite growth ( Figure 4B ).
PfLCN knockdown impairs late stage maturation
To determine which particular parasite stage is affected by the knockdown of PfLCN, we added glucosamine to tightly synchronized LCN-Kd and LCN-Con ring stage parasites and quantified the different parasite stages at 24, 40 and 48 hours post invasion. While we did not see any major effect on trophozoite and schizont numbers upon PfLCN knockdown, there was a substantial reduction of newly formed rings at 48 hpi. As expected, no such effect was seen in LCN-Con parasites after glucosamine addition ( Figure 4D ). To investigate this further, we analyzed schizont morphology in Giemsa-stained blood smears of untreated and glucosamine treated LCN-Kd and LCN-Con parasites that had been incubated with the egress inhibitor compound 2 from 40 to 48 hpi. Interestingly, there was a statistically significant increase of schizonts with abnormal morphology upon glucosamine addition to LCN-Kd parasites, suggesting that PfLCN knockdown affects late stage maturation of the parasite ( Figure 4E ).
PfLCN function affects hemozoin crystal motility in the FV and is related to the activity of ROS
To understand the late stage maturation defect of PfLCN knockdown parasites in more detail, we also studied LCN-Kd and LCN-Con trophozoite stage parasites by live-cell microscopy. Interestingly, glucosamine addition to LCN-Kd but not to LCNCon parasites nearly completely abolished the motion of hemozoin crystals that under normal circumstances move within the food vacuole of individual parasites ( Figure 5A , Movies S3 and S4). Hemozoin dynamics serve as internal biomarker for food vacuole integrity and parasite viability, although the origin and physiological significance of this motion is unknown so far (Sigala & Goldberg, 2014) . A loss of hemozoin crystal motility was previously observed by photoillumination of the heme synthesis intermediate protoporphyrin X due to the generation of ROS (Sigala et al, 2015) . Based on this, we hypothesized that the observed loss of hemozoin crystal motility in PfLCN knockdown parasites is connected to ROS activity. To test this, we induced the knockdown of PfLCN in LCN-Kd parasites in the presence of the radical scavenger Trolox, a water-soluble analog of vitamin E. Remarkably, this resulted in a partial rescue of the hemozoin crystal motility phenotype, implying ROS mediated oxidation in the loss of hemozoin motility ( Figure 5A ). In line with this, treatment of LCN-Kd parasites with the thiol-reactive chemical diamide, which has been shown to induce oxidative stress in the parasite (Rahbari et al, 2017) , also inhibited hemozoin crystal motility. Again, this drug induced motility arrest could partially be restored by the addition of Trolox ( Figure 5B ).
PfLCN reduces oxidative cell damage
To further analyze the importance of ROS, we induced the knockdown of PfLCN in the presence or absence of Trolox. Concordantly with the rescue of hemozoin crystal motility, Trolox treatment chemically complemented around 50% of the growth defect of PfLCN knockdown parasites ( Figure 5C ), suggesting that PfLCN function might be associated with protection from ROS or ROS-induced cell damage. In order to control for the possibility that Trolox treatment non-specifically protects parasites from cell death, we also treated them with the drug DSM1, which targets dihydroorotate dehydrogenase in the mitochondrial electron transport chain leading to inhibition of pyrimidine biosynthesis (Phillips et al, 2008) . However, Trolox treatment failed to restore growth of parasites treated with DSM1 and instead potentiated the activity of the drug ( Figure 5D ). As another control, we conditionally mislocalized the GTPase Rab5a since inactivation of this protein causes a similar phenotype to PfLCN with a defect in late stage parasite maturation (Birnbaum et al, 2017) . Importantly and in contrast to PfLCN knockdown, no difference in growth was observed upon Trolox treatment here ( Figure 5E ), further highlighting the specificity of the Trolox-based rescue of parasite growth upon PfLCN knockdown.
One main source of ROS in infected erythrocytes is the degradation of hemoglobin within the parasite FV (Atamna & Ginsburg, 1993) and this process can be inhibited by application of protease inhibitors (Atamna & Ginsburg, 1993; Mesén-Ramírez et al, 2019) . We therefore tested whether temporal inhibition of hemoglobin digestion through the addition of the cysteine protease inhibitor E64 similarly rescues growth of PfLCN knockdown parasites. To do so, 1 µM E64 was added to ring stage LCN-Kd parasites in presence or absence of glucosamine with E64 being washed away after 12 hours, a treatment that was previously shown to be effective in inhibiting hemoglobin digestion (Mesén-Ramírez et al, 2019) . Temporal E64 application also led to a statistically significant rescue of the PfLCN knockdown-induced growth inhibition ( Figure 5F ), which combined with the ability of Trolox to rescue growth of PfLCN knockdown parasites supports that this protein might have a role in protection from ROS that is produced during hemoglobin digestion in the FV.
Protection from ROS could occur through direct lowering of ROS levels or by mitigating ROS induced cell damage. To differentiate these possibilities, we measured ROS levels in untreated and glucosamine treated LCN-Kd and LCN-Con trophozoite stage parasites by determining the fluorescence intensity of the ROSsensitive dye CellROX Orange ( Figure 5G ). Interestingly, ROS levels were slightly lower in glucosamine treated LCN-Kd parasites in comparison to untreated parasites, while no such effect was visible in glucosamine treated LCN-Con parasites ( Figure  5H ). In parallel to measuring ROS levels, parasite size was also measured in PfLCN knockdown parasites showing a slight decrease in size ( Figure 5I ). It is possible that this difference in size occurs as a result of impaired food vacuole physiology, which may influence CellROX staining intensity as well. Nevertheless, the fact that PfLCN knockdown did not lead to an increase in parasite ROS compared to wildtype parasites during trophozoite development, suggests that it most likely has a role in reducing oxidative stress induced cell damage.
DISCUSSION
Lipocalins are a large family of small proteins that play important roles in various different physiological functions. They are part of the larger calycin protein superfamily and share a highly conserved three-dimensional structure but show unusually low levels of sequence similarity. Due to the extreme sequence diversity amongst lipocalins with pairwise identities falling below 20%, it remains challenging to reliably predict new members of the lipocalin family in genomes using sequence search methods. Predictions that rely on a single computational tool may even miss some of the well-characterized lipocalin family members and therefore, they need to be complemented by different methods. Machine learning approaches have been proposed (Ramana & Gupta, 2009 ), but the currently available algorithms proved unreliable in this study and failed to identify the PfLCN sequence as a lipocalin (Ramana & Gupta, 2009) . Here, using a targeted search informed by libraries of protein signatures and hidden Markov models that are implemented in integrated database resources, we identified a new essential member of the lipocalin protein family in P. falciparum malaria parasites. We confirmed that PfLCN has a typical lipocalin fold through crystallization and structure solution of the protein, which revealed it to be a novel member of the lipocalin family and the first lipocalin characterized in a single-celled eukaryote.
Remarkably, when the crystal structure of PfLCN was solved it was found to be present as a tetramer containing a dimer of dimers. Using SAXS analysis, we confirmed that PfLCN also forms a tetramer in solution and is in a concentrationdependent equilibrium with its dimeric form. This observation excludes that tetramerization is an artefact of the crystallization process. Oligomerization is a common feature of lipocalins and often occurs upon ligand binding (Kielkopf et al, 2018) . The fact that PfLCN was in an oligomeric state in the crystal structure and in solution without a ligand bound suggests that the multimerization of PfLCN occurs independently of its ligand. Interestingly, a higher molecular mass GFP-positive band was also observed in addition to the one corresponding to the monomeric protein, when parasites expressing PfLCN-GFP were analysed by western blotting using GFP antibodies. This band is most likely derived from dimeric PfLCN-GFP and points to a high stability of the putative PfLCN-GFP dimer, as it was not destroyed by the reducing conditions of the SDS-PAGE. In addition, it may indicate that PfLCN can also dimerize in vivo. In this respect it is interesting to note that reducing SDS-PAGE resistant dimers have already been observed for other lipocalins (Bhatia et al, 2012; Van Veen et al, 2006; Kielkopf et al, 2018) .
PfLCN localizes to the main membrane bound vacuolar compartments of the parasite, the PV and the FV. Both compartments are highly sophisticated and have specialized roles that are essential for blood-stage parasite growth. The PV is a bubble-like compartment that is initiated during the process of invasion through the invagination of the erythrocyte membrane. It is bounded by the PVM, which constitutes the parasite-host cell interface and undergoes massive re-modelling after erythrocyte infection is established. The PVM plays a central role in nutrient acquisition, host cell remodelling, waste disposal, environmental sensing, and protection from innate defence mechanisms (reviewed in (Spielmann et al, 2012) ). Likewise, the FV is a unique compartment that is optimized for hemoglobin metabolism. It is the site of acidification, hemoglobin proteolysis, peptide transport, heme polymerization and detoxification of oxygen radicals (reviewed in (Wunderlich et al, 2012) ). In contrast to other organelles (e.g. mitochondrion, apicoplast) the FV, like the PV, does not persist throughout the whole asexual intra-erythrocytic life cycle. It is formed de novo and is discarded at the end of each cycle.
The PV and FV localization of PfLCN are in agreement with a recent study, in which the PfLCN orthologue in the rodent malaria model P. berghei (termed PV5) was identified as an essential PV protein (Matz & Matuschewski, 2018) . The FV localization is further supported by mass spectrometric analysis, which showed that PfLCN is part of the FV proteome (Lamarque et al, 2008) . Given these localizations and the well-established function of lipocalins to transport small hydrophobic molecules (Flower, 1996) , PfLCN may well have a role in transport of hydrophobic molecules (e.g. lipids, fatty acids) from or to the PV/FV. Supporting this, PfLCN has a high structural similarity with the bacterial lipocalin Blc, an E. coli outer membrane lipoprotein, which has been shown to bind fatty acids and lyso-phospholipids and is most likely involved in the transport of these in the bacterium (Campanacci et al, 2006) . However, confirmation of a role for PfLCN in small hydrophobic molecule transport, particularly around the PV, will be addressed in future studies as our results suggest that this protein has another essential role centred on the FV.
Our finding that PfLCN localises to the FV puts in context some of our central observations of the protein knockdown: the loss of hemozoin crystal motility within the FV and the rescue of this motility with a radical scavenger. When we compared the structure of PfLCN to human members of the lipocalin family, it became evident that PfLCN shows high structural similarity to human ApoD. Interestingly, the tetramerization of ApoD under physiological condition has recently been described (Kielkopf et al, 2018) . Human ApoD is capable of binding to a range of small hydrophobic ligands such as progesterone and arachidonic acid and exerts an antioxidant function, which is partially due to the reduction of peroxidized lipids (Bhatia et al, 2012) . This antioxidative function is conserved in ApoD homologs in mice, flies and in the plant Arabidopsis thaliana (Ganfornina et al, 2008; Sanchez et al, 2006; Walker et al, 2006; Charron et al, 2008) . Supporting a similar antioxidative function of PfLCN at the FV, the PfLCN knockdown induced proliferation phenotype could be partially chemically complemented with the radical scavenger Trolox and by temporal inhibition of hemoglobin digestion using the cysteine protease inhibitor E64. ROS levels in PfLCN knockdown parasites were, however, slightly lower in comparison to control parasites. This might be related to the observation that PfLCN knockdown arrests the motion of hemozoin crystals that, under normal circumstances, move dynamically within the FV of individual parasites. This in turn might be a sign of disordered FV physiology, likely associated with reduced hemoglobin digestion and lower amounts of ROS being produced. In addition to this, ROS levels might be influenced by a PfLCN-knockdown associated effect on parasite growth during trophozoite development, as parasite sizes that were measured in parallel to ROS determination, were also slightly reduced in PfLCN knockdown parasites.
Importantly, the lower ROS levels we observed in knockdown parasites argue against a direct function of PfLCN in scavenging of ROS and would instead favour a function similar to human ApoD in mitigating oxidative stress associated cell damage. Human ApoD catalyzes the reduction of peroxidized lipids via a highly conserved methionine residue. Specifically, it reduces peroxidized, potentially radical-generating hydroperoxy eicosatetraenoic acids to the non-reactive hydroxide forms, whereby lipid peroxidation chain reactions are prevented (Bhatia et al, 2012; Dassati et al, 2014) . PfLCN also contains three relatively conserved methionine residues, two of which are within its binding pocket ( Figures S1 and S4) . Therefore, we can speculate that a similar mechanism as described for ApoD might also be used by PfLCN to limit oxidative damage, particularly in the FV. This potential membrane protective effect agrees with our observation that PfLCN not only exists as a soluble protein, but that it also associates with and integrates into membranes. Other lipocalins such as human ApoD attach to the membrane by forming a disulphide bond with a membraneembedded protein, but also use a hydrophobic loop at the opening of the binding pocket to anchor themselves into a membrane (Eichinger et al, 2007; Hernández-Gras & Boronat, 2015) . PfLCN also contains a highly hydrophobic loop (residues 76-79 between β4-β5) that could be used in the same way. This loop contains two residues of the aromatic amino acid phenylalanine, which is often a residue found inserted into membranes (Wang et al, 2009 ). The apparent ability of PfLCN to protect against oxidative damage might explain why PfLCN knockdown parasites show an aberrant late stage development, when massive amounts of new membrane material has to be synthesized and protected from oxidative damage that is the result of Hb digestion in the FV. How this protection may occur on a molecular level and how it is related to the localization of the protein requires further investigation.
Although we have shown in our experiments using the radical scavenger Trolox that one important function of PfLCN is likely its protection against oxidative stress induced cell damage, we only observed a 50% rescue of the PfLCN deletion phenotype upon Trolox treatment. This might on the one hand be due to the fact that not all ROS are scavenged by Trolox at the same efficiency (Sueishi et al, 2014) . On the other hand, it might well be possible that PfLCN has other independent functions from its antioxidative effects, such as fatty acid or lipid transport, which contribute to the formation of abnormal schizonts observed in this study.
Here, we have characterized the first lipocalin in protists that we identified in the Apicomplexan malaria parasite P. falciparum, further broadening the organisms known to possess members of this protein family. Lipocalins have been hypothesized to share an early evolutionary origin in the prokaryotic world, followed by an evolutionary history that has been shaped by gene duplication, gene loss and extreme amino acid divergence in particular lineages (Ganfornina et al, 2000) . Since only a few lipocalin genes have been identified in unicellular eukaryotes and such lipocalins do not align well with the ones found in higher eukaryotes, previous studies provide only limited information on putative evolutionary trajectories. Likewise, our attempts to reconstruct gene phylogenies from highly divergent primary sequences did not provide useful evolutionary insights. We therefore aimed to assess the representation of lipocalins across the tree of life from available whole genome datasets, focussing on extant alveolate taxa. Interestingly, when applying the same search strategy used to identify PfLCN in order to identify putative lipocalins in other alveolate species, we found that many parasitic species either lost or encode only one to few putative lipocalin genes, while in most of their free-living photosynthetic relatives a higher number of putative lipocalin genes can be found, taking different genome sizes into account. Although we cannot rule out intra-species duplications, this finding is in agreement with the paradigm that the transition from free-living to parasitic lifestyle is predominantly characterized by gene loss that has very likely also affected the lipocalin family. Whether or not the lipocalins of other Apicomplexans also play a role in reducing oxidative damage, potentially as a result of host-immune responses (Sorci & Faivre, 2009 ), remains to be determined.
In conclusion, using targeted sequence analysis and by solving its structure using Xray crystallography, we were able to confirm the identity of the first lipocalin in a protist. We show that PfLCN is an essential protein of the malaria parasite P. falciparum, which localizes to the PV and FV. We functionally link PfLCN to oxidative damage control and provide evidence that the antioxidative function of lipocalins not only occurs in mammals, insects and plants but also in a unicellular eukaryote.
MATERIALS AND METHODS
Identification and evolutionary analysis of lipocalin superfamily in Plasmodium falciparum and related protists
Searching the PlasmoDB database (https://plasmodb.org/) for genes annotated as members of the lipocalin superfamily (SSF50814; SUPERFAMILY database (Pandurangan et al, 2019) ) or the calycin homologous superfamily (IPR012674; InterPro (Mitchell et al, 2019) ) revealed the protein coding gene PF3D7_0925900 as putative new lipocalin. We performed batch blastp searches of PfLCN (PF3D7_0925900) against the nr and env_nr database (Agarwala et al, 2018) using Geneious 10.2.3 (https://www.geneious.com) using an E-value of 10e-0 (BLOSUM62 substitution matrix) to identify close homologs in related apicomplexan species. A multiple sequence alignment of putative lipocalins identified in Plasmodium species was performed using MUSCLE implemented in the R package msa v1.16.0 (Bodenhofer et al, 2015) .
We then used the InterPro (Mitchell et al, 2019) and SUPERFAMILY 2.0 database (Pandurangan et al, 2019) to identify and count the number of lipocalin superfamily members in selected alveolate and outgroup species to perform an evolutionary analysis. The R package rotl v3.0.10 (Michonneau et al, 2016) was used to extract a phylogenetic tree from the Open Tree of Life v11.4 synthetic tree (Hinchliff et al, 2015) summarizing current phylogenetic and taxonomic information. Additionally, we obtained genome size data from the NCBI genome database (Agarwala et al, 2018) (https://www.ncbi.nlm.nih.gov/genome/browse) and visualized the phylogenetic tree and associated protein count and genome size data using the R package ggtree v1.16.6 (Yu et al, 2018) .
Protein expression and purification
The coding sequence of PfLCN (corresponding to residues 22-217 and lacking the 21 amino acid N-terminal signal sequence) was PCR amplified from blood stage cDNA using primers recPfLCN-fw and recPfLCN-rev and cloned into the pCoofy1 vector (Scholz et al, 2013) containing an N-terminal hexahistidine tag followed by a 3C PreScission protease site (sequence: LEVLFQG) using the SLiCE cloning method (Zhang et al, 2014) . The vector was transformed into Rosetta-gami 2 (DE3) cells using standard protocols. Cells were grown to an OD 600 of 1.0 in Terrific Broth media at 37°C before induction with 0.5 mM IPTG at 20°C for 18 hours. Cells were pelleted by centrifugation (9373 g) and resuspended in lysis buffer (20 mM Tris pH 7.5, 100 mM NaCl, 20mM imidazole, 5% (v/v) glycerol) before lysis with the Avestin EmulsiFlex C3 french press. Unlysed cells and precipitates were removed by centrifugation (29616 g) and the supernatant was collected and filtered. Filtered lysate was then flowed over Ni-NTA agarose resin at 2.5 ml min -1 before a 7-column volume wash with lysis buffer. PfLCN was eluted using a step gradient with elution buffer (20 mM Tris pH 7.5, 100 mM NaCl, 500 mM imidazole, 5% (v/v) glycerol). Fractions were collected and pooled and 1 mg 3C protease was added. The PfLCN and 3C protease mixture was dialysed against 20 mM Tris pH 7.5, 100 mM NaCl, 5% (v/v) glycerol using 8 kDa MW cut-off dialysis tubing overnight at 4°C. Reverse Ni-NTA was performed to remove cleaved hexahistidine tag and 3C protease and the flowthrough was concentrated in a 10 kDa Amicon Ultra centrifugal filter. Protein was injected onto a HiLoad 16/60 Superdex 75 prep grade size exclusion chromatography column running dialysis buffer at 1 ml min -1 . Fractions were pooled and concentrated using the same Amicon concentrator. The protein concentration was measured using OD 280 on a Nanodrop using the extinction coefficient calculated from the primary sequence before flash freezing and storage at -80°C. All primer sequences are listed in Table S1 .
Crystallization and data collection
Crystallization screenings were carried out using the sitting-drop vapor diffusion method in Swissci plates and with a Mosquito nanolitre-dispensing crystallization robot. 25 mg/ml of recombinant PfLCN in precipitant to protein volume ratios 1:2, 1:1, 2:1 were used for screening in QIAGEN JCSG Core I-IV screens. The crystals appeared around 30 days in 0.1 M Tris pH 7, 0.2 M MgCl 2 , 2.5 M NaCl, and these were cryoprotected in the same buffer plus 20% glycerol. X-ray diffraction data were collected at 100° K on beamline P13 (PETRA III, EMBL Hamburg) using a wavelength of 0.976 Å.
Structure determination
All work was performed using the CCP4i2 (Potterton et al, 2018) suite unless stated. The dataset was integrated using XDS (Kabsch, 2010) and scaled using AIMLESS (Evans & Murshudov, 2013) . The solution of the tetrameric asymmetric unit was obtained by molecular replacement using Phaser (McCoy et al, 2007) with a model generated and modified by the Phenix MRage pipeline (Bunkóczi et al, 2013 ) based on Blc from E. coli (PDB code 3MBT). The initial model was built by Buccaneer (Cowtan, 2006) , refined in real space with Coot (Emsley et al, 2010) and reciprocal space with REFMAC5 (Murshudov et al, 2011) . Structure was validated using Molprobity (Williams et al, 2018) and displayed using Chimera (Pettersen et al, 2004) .
SAXS and SEC-SAXS
Synchrotron SAXS data were measured from the PfLCN protein through a concentration series using a standard batch setup as well as in-line size-exclusion chromatography SAXS (SEC-SAXS). All samples were reconstituted in 20 mM Tris pH 7.5, 100 mM NaCl, 5% v/v glycerol. The data were collected on the EMBL P12 beamline at PETRA III (Hamburg, Germany) equipped with Pilatus 6M detector at a sample-detector distance of 3 m and at a wavelength of λ = 0.124 nm (I(s) vs s, where s = 4πsinθ/λ, and 2θ is the scattering angle). For the batch measurements, the sample concentrations were: 10, 5, 2 and 1 mg/ml (20 successive 0.050 second frames were collected for each sample at 10° C, in addition to the corresponding matched solvent blank). The data were normalized to the intensity of the transmitted beam and radially averaged and the scattering of the solvent-blank was subtracted to generate the SAXS data displayed in this entry. The SEC parameters were as follows: A 75 µl sample at 10 mg/ml was injected at a flow rate of 0.35 ml/min onto a GE Superdex 200 Increase 10/300 column at 20°C. 56 successive 1 second frames were collected through the major SEC-elution peak and processed using CHROMIXS that included the subtraction of an appropriate solvent blank measured from the protein-free column eluate.
P. falciparum culture and transfection
Blood stages of P. falciparum parasites (strain 3D7) were cultured in human RBCs (O+) (transfusion blood, Universitätsklinikum Hamburg Eppendorf, Hamburg). Cultures were maintained at 37° C in an atmosphere of 1% O 2 , 5% CO 2 , and 94% N 2 and cultured using RPMI complete medium containing 0.5% Albumax according to standard procedures (Trager & Jensen, 1976) . For transfection of constructs, 60% Percoll-enriched synchronized mature schizonts were electroporated with 50 µg of plasmid DNA using a Lonza Nucleofector II device (Moon et al, 2013) . Selection was done either with 3 nM WR99210 or 0.9 µM DSM1 (BEI Resources; https://www.beiresources.org). For generation of stable integrant cell lines, parasites containing the episomal plasmids selected with WR were grown with 400 µg/ml G418 to select for integrants carrying the desired genomic modification as described previously (Birnbaum et al, 2017) .
Cloning of constructs for parasite transfection
To generate the plasmid pSLI-PfLCN-TGD, 258 bp of the n-terminal PfLCN coding sequence was amplified by PCR from genomic DNA using primers PfLCN-TGD-fw and PfLCN-TGD-rev and cloned into pSLI-TGD-GFP (Birnbaum et al, 2017) using NotI and MluI restriction sites.
To generate pSLI-GFP-GlmS-WT and pSLI-GFP-GlmS-M9, the glmS-WT and glmS-M9 sequences were amplified by PCR from pARL-HA-glmS (Flammersfeld et al, 2019) using primers GlmS-WT-fw/GlmS-rev (WT) or GlmS-M9-fw/GlmS-rev (M9) and cloned via XhoI into pSLI-TGD-GFP (Birnbaum et al, 2017) . Next, 498 bp of the cterminal PfLCN coding sequence omitting the stop codon were amplified by PCR from genomic DNA using PfLCN-GFP-fw and PfLCN-GFP-rev and cloned via NotI and MluI into pSLI-GFP-GlmS-WT and pSLI-GFP-GlmS-M9 to generate the final targeting constructs pSLI-PfLCN-GFP-GlmS-WT and pSLI-PfLCN-GFP-GlmS-M9.
For generation of the PfLCN gene complementation vector pNMD3:PfLCN-mCherry-DHODH, the PfLCN coding sequence without stop codon was amplified by PCR from genomic DNA using primers PfLCN-Comp-fw and PfLCN-Comp-rev and cloned via XhoI and SpeI into the pNMD3:1xNLS-FRB-mCherry-DHODH plasmid (Birnbaum et al, 2017) replacing the 1xNLS-FRB sequence with the PfLCN coding sequence. All primer sequences are listed in Table S1 .
Generation of Lip-Kd and Lip-Con parasites and PfLCN gene complementation
The two targeting constructs pSLI-PfLCN-GFP-GlmS-WT and pSLI-PfLCN-GFPGlmS-M9 were transfected as described above into P. falciparum 3D7 parasites, which were then subjected to sequential WR and G418 selection resulting in LCN-Kd (GlmS-WT) and LCN-Con (GlmS-M9) parasites. To confirm correct integration, genomic DNA from parasites selected under G418 as well as from 3D7/WT parasites was prepared with the QIAamp DNA Mini Kit and analyzed by PCR using primers specific for the 5' and 3' integration junctions of the PfLCN locus and primers to detect the original locus. For gene complementation of PfLCN, LCN-Kd parasites were transfected with the pNMD3:PfLCN-mCherry-DHODH plasmid and transgenic LCN-Comp parasites were selected by DSM1. All primer sequences are listed in Table S1 .
Live cell microscopy
For live cell microscopy, LCN-Kd parasites were incubated with 1 µg/ml DAPI in culture medium for 15 minutes at 37°C to stain nuclei. Parasites were then washed once in PBS and imaged in PBS on a Leica D6B fluorescence microscope equipped with a Leica DFC9000 GT camera and a Leica Plan Apochromat 100x/1.4 oil objective. Image processing was performed using ImageJ.
Solubility analysis of PfLCN
For determination of membrane association, trophozoite stage LCN-Kd parasites from two 10 ml dishes (4% hematocrit, 5-10% parasitemia) were isolated using a Percoll gradient as previously described (Heiber & Spielmann, 2014) and released from RBCs using 0.03% saponin in 200 µl of PBS for 10 minutes (if not otherwise indicated, all steps were carried out on ice). After centrifugation at 16.000 g for 10 minutes, the pellet was 3x washed in PBS, complete protease inhibitor (Roche) was added to the pellet and the parasites were lysed in 200 µl of 5 mM Tris-HCl pH 8.0 and frozen at -80°C. After another three freeze thaw cycles in liquid nitrogen, extraction was performed sequentially: The lysate was centrifuged at 16.000 g for 10 min. The supernatant was removed, recentrifuged for 5 min to remove residual insoluble material and saved as the soluble protein fraction. The pellet of the hypotonic lysis was resuspended in 200 µl of freshly prepared 0.1 M Na 2 CO 3 and stored on ice for 30 min to extract peripheral membrane proteins. After centrifugation, the supernatant was saved, the pellet extracted for 30 min with 200 µl 1% Triton X-100 and centrifuged to obtain the integral membrane protein fraction in the supernatant. The pellet was resuspended in PBS, representing the insoluble fraction. Reducing SDS sample buffer was added to all supernatants as well as to the insoluble fraction and equal amounts of all samples were analyzed by SDSpolyacrylamide gel electrophoresis (PAGE) and western blotting.
Immunoblotting analysis
Protein samples were resolved by SDS-PAGE and transferred to nitrocellulose membranes (LICOR). Membranes were blocked in 5% milk in TBS-T followed by incubation in the following primary antibodies that were diluted in TBS-T containing 5% milk: mouse-anti-GFP (Sigma, 1:1000), rabbit-anti-aldolase (Mesén-Ramírez et al, 2016 ) (1:2000 , mouse-anti-SBP1-N (Mesén-Ramírez et al, 2016 ) (1:2000 . After 3x washing in TBST-T, membranes were incubated in similarly diluted secondary antibodies: goat-anti-mouse-800CW (LICOR, 1:10.000), goat-anti-rabbit-680RD (LICOR, 1:10.000) and goat-anti-mouse-680RD (LICOR, 1:10.000). Subsequently, membranes were washed another 3 times with TBST-T and scanned on a LICOR Odyssey FC imager.
PfLCN knockdown and phenotypic characterization
To induce knockdown of PfLCN, 2.5 mM glucosamine was added to highly synchronous ealy rings stage LCN-Kd parasites. As a control, the same amount of glucosamine was also added to LCN-Con parasites. For all analyses, medium was changed daily and fresh glucosamine and/or compounds were added every day.
For quantification of knockdown efficiency, untreated and gluocosamine treated LCNKd and LCN-Con trophozoite stage parasites from one 10 ml dish (4% hematocrit, 5-10% parasitemia) were isolated using a Percoll gradient 24 hours after glucosamine addition as previously described (Heiber & Spielmann, 2014) , directly lysed in reducing SDS-sample buffer and analyzed by SDS-Page and western blotting as explained above. Quantifications of PfLCN-GFP and aldolase levels were performed using the LICOR Image Studio software.
For growth analyses over four parasite cycles, highly synchronous early ring stage parasites were diluted to approximately 0.1% parasitemia in 2 ml dishes (5% hematocrit) and analyzed by FACS as trophozoite stage parasites 1, 3, 5, and 7 days post invasion. After analysis on day 5, parasites were split 1:10 to prevent overgrowth of cultures. For growth analyses over one parasite cycle, highly synchronous ring-stage cultures were diluted to 1% parasitemia in 2 ml dishes and were analyzed by flow cytometry in the subsequent cycle as trophozoite stage parasites.
Flow cytometry-based analysis of growth was performed basically as described previously (Malleret et al, 2011) . In brief, 20 µl resuspended parasite culture was incubated with dihydroethidium (5 µg/ml) and SYBR green (0.25 x dilution) in medium for 20 minutes at room temperature protected from light. For every sample, 100.000 events were recorded using an ACEA NovoCyte flow cytometer and parasitemia was determined based on SYBR green fluorescence.
For stage quantifications and analysis of schizont morphology, schizont stage parasites were isolated by percoll purification and incubated with uninfected RBCs for three hours to allow rupture and invasion. Parasites were then treated with sorbitol to remove any unruptured schizonts, leading to a 3h synchronous ring stage culture. Next, parasite cultures were diluted to approximately 1% parasitemia in 2 ml dishes (5% hematocrit) and Giemsa-stained blood smears were prepared at 24, 40 and 48 hours post invasion. For analysis of schizont morphology, 1 µM of the egress inhibitor compound 2 was added to schizont stage parasites at 40 hours post invasion. After 8 hours, Giemsa-stained blood smears were prepared and schizont morphology was investigated by light-microscopy.
Haemozoin crystal motility assay
Schizont stage parasites were isolated by 60% percoll purification and incubated with uninfected RBCs for three hours to allow rupture and invasion. After 3 hours, parasites were treated with sorbitol to remove any unruptured schizonts. Newly invaded rings were then transferred to a 5 mL culture dish (4% haematocrit). Parasites were left untreated or treated with 2.5 mM glucosamine in presence or absence of 100 µM Trolox for 27 hours under standard culture conditions until transfer onto imaging dishes. Treatments with 10 µM diamide in presence or absence of 100 µM Trolox were initiated 24 hours after sorbitol treatment and lasted for 3 hours before parasites were also transferred onto imaging dishes. After the respective treatments, parasites were washed with PBS and trophozoites were isolated by using a Percoll gradient (Heiber & Spielmann, 2014) . Enriched trophozoites were then resuspended in 500 µl of complete medium (if necessary with glucosamine, Trolox or diamide) and parasites were allowed to settle on 4 chamber glass bottom dishes (In Vitro Scientific) for 1 hour under standard culture conditions. Imaging dishes were concanavalin A coated beforehand by incubation with 0.5 mg/ml concanavalin A dissolved in H 2 O for 15 minutes at 37°C followed by washing with PBS. Parasites were then imaged using an inverted Leica DFC9000 GT camera and a Leica Plan Apochromat 100x/1.4 oil objective and were kept at 37°C for the duration of the experiment. To generate the videos used for assessing hemozoin crystal motility, one image per second was taken over an imaging period of one minute. For quantifications, video files were imported into ImageJ, where the total number of parasites and the number of parasites with motile hemozoin crystals were quantified.
Measurement of oxidative stress
For measurement of oxidative stress levels, LCN-Kd and LCN-Con ring stage parasites were treated with 2.5 mM glucosamine or were left untreated. At around 30 hours post-invasion, trophozoite stage parasites were stained with 5 µM CellROX orange (ThermoFisher Scientific) in culture medium for 30 minutes at 37°C. After three washes with PBS, they were directly imaged on a Leica D6B fluorescence microscope as described above. Mean fluorescence intensities and size (area) of individual parasites were determined using the ROI manager of ImageJ.
Statistical analysis
For statistical analysis of differences between two groups, an unpaired two-tailed students t-test or a ratio-paired two-tailed t-test was used. For statistical analysis of differences between more than two groups, a one-way analysis of variance (ANOVA), followed by a Holm-Sidak multiple-comparison test was performed. P values of <0.05 were considered significant.
Data availability
All data generated or analyzed during this study are included in this published article and its supplemental material files. The structural data have been deposited in the PDB under the accession code 6TLB. All SAXS data is available on the SASBDB under the accession code SASDH92. A) SAXS raw data taken over a range of concentration of PfLCN in batch mode, also including a SEC-SAXS run. From bottom to top, the data sets are: SEC-SAXS run, 1 mg ml -1 , 2 mg ml -1 , 5 mg ml -1 and 10 mg ml -1 . The fitted lines represent the calculated scattering from the tetramer-dimer mixtures given in Figure 2D , using the software SASREFMX. The Χ 2 functions of each fit are respectively: 0.98, 0.98, 1.0, 1.2, 1.3. The datasets are offset by a factor of 10 each time for clarity. B) Graph shows concentration of PfLCN plotted against average molecular weight (Mw) of the sample on the left y axis. On the right y axis is the ratio of this Mw compared to the monomer Mw. The SEC-SAXS sample is not plotted on the graph as it is not possible to work out the protein concentration using this technique. C) The average hydrodynamic radius (R g ) plotted against concentration. D) The proportion of tetrameric and dimeric PfLCN present at different concentrations, calculated using the software SASREFMX. A) Western blot of LCN-Kd and LCN-Con trophozoite stage parasites, which had been treated for 24 hours with 2.5 mM glucosamine or that were left untreated. Aldolase served as a loading control. Quantification of monomeric PfLCN-GFP levels normalized to the amount of aldolase is displayed on the right. Shown are means +/-SD of three independent experiments, in which PfLCN-GFP levels of untreated Figure 5 . PfLCN protects parasites against oxidative stress induced cell damage. A) Hemozoin crystal motility analysis of LCN-Kd and LCN-Con trophozoite stage parasites grown in the presence or absence of 2.5 mM glucosamine. In a separate culture, 100 uM of the radical scavenger Trolox was added to LCN-Kd knockdown parasites. B) Hemozoin crystal motility analysis of LCN-Kd trophozoite stage parasites to which 10 µM diamide in presence or absence of 100 µM Trolox was added for 4 hours before analysis. Shown are means +/-SD of five independent experiments. For statistical comparisons a one-way ANOVA followed by a HolmSidak multiple comparison test was performed. Statistically significant differences are indicated (* p < 0.05, *** p < 0.001, **** p < 0.0001, n.s. = not significant). Please see also Movies S3 and S4. C, D) Growth analysis of LCN-Kd parasites over one parasite cycle grown in presence or absence of 2.5 mM glucosamine or 0.24 µM DSM1 to which 100 µM Trolox were added or that were left untreated. E) Growth analysis over one parasite cycle of Rab5a knocksideways parasites grown in presence or absence of 40 nM Rapalog to which 100 µM Trolox were added or that were left untreated. Note that the amounts of DSM1 and Rapalog were chosen to 
